60 mg
Trade Name
Filozad
Powder for solution for injection
Request Type
New Registration
Drug Type
Generic
Approval Date
SFDA Approved Use
Carfilzomib indicated for the treatment of adult patients with relapsed or refractory multiple myeloma who have received one to three lines of therapy in combination with:
Lenalidomide and dexamethasone; or Dexamethasone; or Daratumumab and dexamethasone.
Carfilzomib indicated as a single agent for the treatment of adult patients with relapsed or refractory multiple myeloma who have received one or more lines of therapy.
Lenalidomide and dexamethasone; or Dexamethasone; or Daratumumab and dexamethasone.
Carfilzomib indicated as a single agent for the treatment of adult patients with relapsed or refractory multiple myeloma who have received one or more lines of therapy.